돼지열병 백신 시장 규모는 2024년에 16억 달러로 평가되었고 2026-2032년에 걸쳐 CAGR 5.1%를 나타내 2032년에는 26억 달러에 달할 것으로 예측되고 있습니다.
돼지열병 백신 시장 성장 촉진요인은 다양한 요인의 영향을 받을 수 있습니다.
돼지 인구 증가 : 특히 아시아나 라틴아메리카와 같은 지역에서는 세계 돼지 인구가 계속 증가하고 있기 때문에 돼지열병과 같은 질병을 예방하기 위한 효율적인 백신의 필요성이 증가하고 있습니다.
정부의 이니셔티브와 규제 : 돼지 독감의 발생을 관리하고 차단하기 위해 정부와 규제 기관은 예방 접종 프로그램을 자주 의무화하고 있습니다.
질병 발생에 대한 우려 증가 : 돼지 부문은 돼지열병의 발생으로 인해 큰 경제적 손실을 입을 수 있습니다.
기술 개발 : 보다 안전하고 효과적인 예방 접종의 개발은 백신 산업이 시장 확대를 지원하는 기술적 진보의 한 측면입니다.
교육과 의식 증가 : 시장 수요를 견인하는 것은 양돈 농업 종사자가 예방 접종과 질병 예방의 가치에 대해 이해를 깊게하는 것입니다.
양돼지 산업의 세계화 : 돼지 고기 산업은 국가와 지역을 넘어 서로 관련되어 있기 때문에 질병의 발생은 큰 영향을 미칠 수 있습니다.
R & D 투자 : 생명 공학 및 제약 회사의 R & D 투자의 결과로 더 나은 돼지열병 백신이 새롭게 개발됩니다.
동물의 건강과 복지의 중시 : 축산업이 동물의 건강과 복지의 기준을 보다 중시하게 되어, 돼지열과 같은 질병을 막기 위한 백신 접종을 장려하게 되어, 시장의 확대를 뒷받침하고 있습니다.
세계의 돼지열병 백신 시장 성장 억제요인
돼지열병 백신 시장에는 몇 가지 요인이 억제요인이나 과제로 작용할 수 있습니다.
규제상의 과제 : 엄격한 안전 기준과 규제로 인해 돼지열병 백신의 승인을 취득하는 데는 비용과 시간이 걸립니다.
제한된 지식과 교육 : 일부 지역에서는 농업 종사자와 가축 소유자가 돼지열병 백신의 이점을 충분히 이해하지 못할 수 있습니다.
백신 접종 프로그램의 고액 비용 : 농업 종사자와 정부는 대규모 돼지 군을 종합적인 백신 접종 프로그램에 참여시키는 경우 많은 비용이 소요될 수 있습니다.
물류의 어려움 : 백신의 보관과 배송을위한 콜드체인의 유지는 원격지와 지방에 대한 효율적인 백신 배포에서 물류 문제 중 하나입니다.
효능과 안전성 문제 : 제조자들에게 돼지 인플루엔자 예방접종의 효능과 안전성은 가장 중요합니다.
경쟁 시장 환경 : 가격 경쟁과 제품 차별화는 시장에 여러 백신 생산자와 제품이 존재하기 때문에 발생할 수있는 경쟁 압력의 두 가지 예입니다. 경쟁 구도는 개별 백신 공급업체의 확대를 제한하고 시장의 일반적인 역학에 영향을 줄 수 있습니다.
무역 장벽과 수출 문제 : 돼지열병 발생으로 인해 영향을 받은 지역을 원산지로 하는 돼지 제품의 무역이 제한될 수 있습니다.
Swine Fever Vaccine Market size was valued at USD 1.6 Billion in 2024 and is projected to reach USD 2.6 Billion by 2032, growing at a CAGR of 5.1% during the forecast period 2026-2032.
The market drivers for the Swine Fever Vaccine Market can be influenced by various factors. These may include:
Growing Swine Population: There is an increasing need for efficient vaccines to prevent diseases like swine fever as the world's pig population continues to grow, particularly in areas like Asia and Latin America.
Government Initiatives and Regulations: To manage and stop swine flu outbreaks, governments and regulatory agencies frequently require vaccination programmes. The market for swine flu vaccinations is driven by laws and policies that are supportive.
Growing Fears Regarding Disease Outbreaks: The swine sector may suffer large financial losses as a result of swine fever outbreaks. The significance of these epidemics is becoming more widely recognised among farmers and other stakeholders, which is driving up demand for vaccinations as a preventive strategy.
Technological developments: The creation of safer and more effective vaccinations is one aspect of the vaccine industry's technological advancements that support market expansion. This covers developments in adjuvant technology, vaccination formulation, and delivery techniques.
Growing Education and Awareness: Market demand is driven by swine farmers' growing understanding of the value of immunisation and illness prevention. Campaigns for education that emphasise the advantages of vaccinations for the prevention and control of disease are important.
Globalisation of the Swine Industry: Disease outbreaks can have a significant impact due to the interconnectedness of the swine industry across nations and regions. Strong immunisation programmes are required, and this globalisation element propels market expansion.
Research and Development Investments: New and better swine fever vaccines are developed as a result of research and development investments made by biotech and pharmaceutical companies. Competitiveness and commercial expansion are fueled by these developments.
Focus on Animal Health and Welfare: As the livestock business places a greater emphasis on animal health and welfare standards, vaccination use to ward off diseases like swine fever is encouraged, which propels market expansion.
Global Swine Fever Vaccine Market Restraints
Several factors can act as restraints or challenges for the Swine Fever Vaccine Market . These may include:
Regulatory Challenges: Due to strict safety standards and regulatory regulations, obtaining regulatory approval for swine fever vaccines can be costly and time-consuming. This procedure may delay the release of new products and serve as a barrier to entry for new competitors.
Limited Knowledge and Education: In certain areas, farmers and livestock owners might not be fully informed of the advantages of swine fever vaccine. This may result in slower adoption rates and decreased demand for vaccinations, especially in regions with fewer swine flu outbreaks.
High Expense of Vaccination Programmes: Farmers and governments may incur significant expenses when putting big swine populations through comprehensive vaccination programmes. Vaccine procurement, administration, and schedule management costs can be a major barrier, particularly for small-scale farms in areas with scarce resources.
Logistical Difficulties: Maintaining the cold chain for vaccine storage and delivery is one logistical problem in the efficient distribution of vaccinations to remote or rural locations. These administrative obstacles may limit vaccination accessibility for all swine farmers, which may have an effect on market penetration.
Efficacy and Safety Concerns: For manufacturers, the effectiveness and safety of swine flu vaccinations are paramount. The effectiveness of vaccines against various virus strains, possible side effects, and long-term immunity are some of the issues that can affect producer trust in vaccination programmes and adoption rates.
Competitive Market Environment: Price wars and product differentiation are two examples of the competitive pressures that can arise from the existence of several vaccine producers and products on the market. The competitive landscape could limit the expansion of individual vaccine suppliers and affect the general dynamics of the market.
Trade Barriers and Export Issues: Outbreaks of swine fever may result in trade restrictions on pig products originating from impacted areas. Because producers would be hesitant to invest in immunisation programmes due to doubts about market access and export potential, this could have an indirect effect on the demand for swine fever vaccinations.
The Global Swine Fever Vaccine Market is segmented on the basis of Product, Application, and Geography.
Based on Product, The market is segmented into Tissue Culture Origin and Cell Line Origin. The Tissue Culture Origin segment is anticipated to dominate the Global Swine Fever Vaccine Market. The US biopharmaceutical industries heavily rely on cell culture for tissue culture, drug research, and vaccine manufacture. The segment is expected to develop significantly since tissue culture is vital in the traditional Swine Fever Vaccine.
Based on Application, The market is segmented into Government Tender and Market Sales. The Government Tender segment is anticipated to dominate the Global Swine Fever Vaccine Market. Due to the government's intense attention on preventing the spread of classical swine disease, a government tender for the sale of the vaccine is set.